Latest News about CMPS
Recent news which mentions CMPS
Psychedelics-Focused Compass Pathways Has Established Itself As 'Credible CNS Biotechnology Company,' Analyst Says
February 27, 2025
From Benzinga
Compass Pathways Plc (CMPS) Q4 2024 Earnings Call Transcript
February 27, 2025
Tickers
CMPS
From Motley Fool
This Plumas Bancorp Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday
February 27, 2025
From Benzinga
Earnings Scheduled For February 27, 2025
February 27, 2025
From Benzinga
Is Your Mind Ready to Consider Investing in Psychedelics Stocks?
November 29, 2024
From Motley Fool
COMPASS Pathways: Institutional Pressure Amid $43M Market Cap Decline, What's Next For This Psychedelics Co?
November 25, 2024
From Benzinga
From Benzinga
From Benzinga
AI And Psychedelics: A Marriage Made In Heaven For Mental Health Care?
November 13, 2024
From Benzinga
Top 3 Health Care Stocks You'll Regret Missing In November
November 05, 2024
From Benzinga
Compass Pathways Plc (CMPS) Q3 2024 Earnings Call Transcript
October 31, 2024
Tickers
CMPS
From Motley Fool
Nasdaq Down 500 Points; Uber Shares Dip After Q3 Results
October 31, 2024
From Benzinga
As Psilocybin Trials Face Delays, Compass Pathways (CMPS) Cuts Workforce To Conserve Cash
October 31, 2024
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 31, 2024
From Benzinga
Crude Oil Gains 1%; Meta Shares Fall Following Q3 Results
October 31, 2024
From Benzinga
Estée Lauder, Robinhood, eBay And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
October 31, 2024
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 31, 2024
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 31, 2024
From Benzinga
Uncovering Potential: Compass Pathways's Earnings Preview
October 30, 2024
Tickers
CMPS
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
October 25, 2024
From Benzinga
Could Psilocybin Be A Game-Changer For Millions Battling Depression? New Study Says Yes
October 07, 2024
From Benzinga
Psilocybin Breakthrough: Study Reveals Potential Application For Body Dysmorphic Disorder
September 26, 2024
From Benzinga
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
September 12, 2024
From Benzinga
Shake Up At Lykos Therapeutics After FDA Blocks Ecstasy-Based Treatment, CEO Steps Down
September 05, 2024
From Benzinga
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
September 05, 2024
From Benzinga
From Benzinga
Compass Pathways Plc (CMPS) Q2 2024 Earnings Call Transcript
August 01, 2024
Tickers
CMPS
From Motley Fool
EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves
July 31, 2024
From Benzinga
3 Dirt-Cheap Drug Developers With Blockbuster Potential
July 11, 2024
From InvestorPlace
3 Next-Gen Drug Stocks Exploring Psychedelic Frontiers
July 08, 2024
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.